The correct IUPAC name for the given compound has to be chosen from the given options. Concept Introduction: IUPAC nomenclature for alkene : There are about eight rules to be followed in giving IUPAC name for alkene. The suffix –ane has to be replaced with the suffix –ene. This is used to indicate the presence of double bond. The longest continuous chain of carbon atoms has to be chosen that contains both carbon atoms of the double bond. The parent carbon chain has to be numbered in a way so that the numbering begins at the end near to the double bond. In case if the double bond is equidistant from both ends, then numbering has to be done from the end that is closer to substituents. The position of the double bond has to be given a single number which is lower‑numbered carbon atom that is present in the double bond. Suffixes like –diene, -triene, -tetrene, and so on are used when the compound contains more than one double bond. In case of cycloalkenes which do not have any substitution, the numbering is not needed to locate the double bond because the bond is assumed to be between the carbons 1 and 2. In case if substituents are present in cycloalkene, then the double‑bonded carbon atoms are numbered 1 and 2 in a direction where the substituent gets the lower number. If the cycloalkenes contain more than one double bond, then one double bond is assigned the numbers 1 and 2 followed by the other double bond so that the lowest number possible is given.

Question

According to a recent study, 1 out of 50,000 people will be diagnosed with cystic fibrosis. Cystic fibrosis can be caused by a mutant form of the CFTR gene (dominant gene symbol is F and mutant is f). A. Using the rate of incidence above, what is the frequency of carriers of the cystic fibrosis allele for CFTR in the US? (3 pts) B. In a clinical study, 400 people from the population mentioned in (A.) were genotyped for BRCA1 Listed below are the results. Are these results in Hardy- Weinberg equilibrium? Use Chi Square to show whether or not they are. (3 pts) BRCA1 genotype # of women 390 BB Bb bb 10 0 12pt Paragraph L BIUAV V T² v V

Answer 1

Question

Chapter 13.3, Problem 1QQ

Interpretation Introduction

Interpretation:

The correct IUPAC name for the given compound has to be chosen from the given options.

Concept Introduction:

IUPAC nomenclature for alkene: There are about eight rules to be followed in giving IUPAC name for alkene.

The suffix –ane has to be replaced with the suffix –ene. This is used to indicate the presence of double bond.

The longest continuous chain of carbon atoms has to be chosen that contains both carbon atoms of the double bond.

The parent carbon chain has to be numbered in a way so that the numbering begins at the end near to the double bond. In case if the double bond is equidistant from both ends, then numbering has to be done from the end that is closer to substituents.

The position of the double bond has to be given a single number which is lower‑numbered carbon atom that is present in the double bond.

Suffixes like –diene, -triene, -tetrene, and so on are used when the compound contains more than one double bond.

In case of cycloalkenes which do not have any substitution, the numbering is not needed to locate the double bond because the bond is assumed to be between the carbons 1 and 2.

In case if substituents are present in cycloalkene, then the double‑bonded carbon atoms are numbered 1 and 2 in a direction where the substituent gets the lower number.

If the cycloalkenes contain more than one double bond, then one double bond is assigned the numbers 1 and 2 followed by the other double bond so that the lowest number possible is given.

Expert Solution & Answer

Trending nowThis is a popular solution!

See solution

Check out sample textbook solution

Students have asked these similar questions

According to a recent study, 1 out of 50,000 people will be diagnosed with cystic fibrosis. Cystic fibrosis can be caused by a mutant form of the CFTR gene (dominant gene symbol is F and mutant is f). A. Using the rate of incidence above, what is the frequency of carriers of the cystic fibrosis allele for CFTR in the US? (3 pts) B. In a clinical study, 400 people from the population mentioned in (A.) were genotyped for BRCA1 Listed below are the results. Are these results in Hardy- Weinberg equilibrium? Use Chi Square to show whether or not they are. (3 pts) BRCA1 genotype # of women 390 BB Bb bb 10 0 12pt Paragraph L BIUAV V T² v V

Outline a method for using apomixis to maintain feminized CannabisAssume apomixis is controlled by a single dominant gene. You can choose the type of apomixis: obligate or facultative, gametophytic or sporophytic. Discuss advantages and disadvantages of your proposed method.

Kinetics: One-Compartment First-Order Absorption 1. In vivo testing provides valuable insight into a drug’s kinetics. Assessing drug kinetics following multiple routes of administration provides greater insight than a single route of administration alone. The following data was collected in 250-g rats following bolus IV, oral (PO), and intraperitoneal (ip) administration. Using this data and set of graphs, determine:(calculate for each variable) (a) k, C0, V, and AUC* for the bolus iv data (b) k, ka, B1, and AUC* for the po data c) k, ka, B1, and AUC* for the ip data (d) relative bioavailability for po vs ip, Fpo/Fip (e)absolute ip bioavailability, Fip (f) absolute po bioavailability, Fpo